Cargando…

Recommendations for the Implementation of Hospital Based HTA in Poland: Lessons Learned From International Experience

Introduction: The main challenge of modern hospitals is purchasing medical technologies. Hospital-based health technology assessments (HB-HTAs) are used in healthcare facilities around the world to support management boards in providing relevant technologies for patients. Aim: This study was underta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gałązka-Sobotka, Małgorzata, Kowalska-Bobko, Iwona, Lach, Krzysztof, Mela, Aneta, Furman, Maciej, Lipska, Iga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155722/ https://www.ncbi.nlm.nih.gov/pubmed/34054508 http://dx.doi.org/10.3389/fphar.2020.594644

Ejemplares similares

Possibilities of Implementing Hospital-Based Health Technology Assessment (HB-HTA) at the Level of Voivodeship Offices in Poland
por: Furman, Maciej, et al.
Publicado: (2022)

HB-HTA as an implementation problem in Polish health policy
por: Gałązka-Sobotka, Małgorzata, et al.
Publicado: (2021)

Implementation of Mental Health Centres Pilots in Poland since 2018: A Chance to Move towards Community-Based Mental Health Services
por: Sagan, Anna, et al.
Publicado: (2022)

Economic Costs of Cardiovascular Diseases in Poland Estimates for 2015–2017 Years
por: Mela, Aneta, et al.
Publicado: (2020)

The Need to Implement Health Technology Assessment in Polish Hospitals—A Survey of 50 Hospital Managers
por: Farkowski, Michał M., et al.
Publicado: (2022)

Assessing Recent Efforts to Improve Organization of Cancer Care in Poland: What Does the Evidence Tell Us?
por: Sagan, Anna, et al.
Publicado: (2022)

The Devil Is in the Data: Can Regional Variation in Amenable Mortality Help to Understand Changes in Health System Performance in Poland?
por: Sagan, Anna, et al.
Publicado: (2022)

Health Centres 75+ as a New Model to Improve Care for Older People in Poland
por: Sagan, Anna, et al.
Publicado: (2022)

Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
por: Lach, Krzysztof, et al.
Publicado: (2017)

Reimbursement decision-making system in Poland systematically compared to other countries
por: Mela, Aneta, et al.
Publicado: (2023)

A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?
por: Allen, Nicola, et al.
Publicado: (2017)

Addressing health corruption during a public health crisis through anticipatory governance: Lessons from the COVID-19 pandemic
por: Gonzalez-Aquines, Alejandro, et al.
Publicado: (2022)

Navigating HTA implementation: a review of Indonesia’s revised HTA guideline
por: Chavarina, Kinanti Khansa, et al.
Publicado: (2023)

Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years
por: Mela, Aneta, et al.
Publicado: (2020)

What is being done to respond to the rise of chronic diseases and multi-morbidity in Czechia, Hungary, Poland, and Slovakia?
por: Sagan, Anna, et al.
Publicado: (2023)

Nutrition, a health technology that deserves increasing interest among HTA doers. A systematic review
por: Gutiérrez-Ibarluzea, Iñaki, et al.
Publicado: (2015)

Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective
por: Kisser, Agnes, et al.
Publicado: (2021)

The Prevalence of Selected Potential Drug-Drug Interactions of Analgesic Drugs and Possible Methods of Preventing Them: Lessons Learned From the Analysis of the Real-World National Database of 38 Million Citizens of Poland
por: Kardas, Przemysław, et al.
Publicado: (2021)

Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïve metastatic clear-cell renal cell carcinoma—A network meta-analysis. Focus on cabozantinib combined with nivolumab
por: Niewada, Maciej, et al.
Publicado: (2023)

Health Care Organization in Poland in Light of the Refugee Crisis Related to the Military Conflict in Ukraine
por: Prusaczyk, Artur, et al.
Publicado: (2023)

HTA Implementation Roadmap in Central and Eastern European Countries
por: Kaló, Zoltán, et al.
Publicado: (2016)

Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile
por: Wang, Ting, et al.
Publicado: (2022)

The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe
por: Kawalec, Paweł, et al.
Publicado: (2016)

Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA: Comment on "Ethics in HTA: Examining the ‘Need for Expansion’"
por: Culyer, Anthony J.
Publicado: (2019)

Remodeling an existing rare disease registry to be used in regulatory context: Lessons learned and recommendations
por: Mordenti, Marina, et al.
Publicado: (2022)

Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges
por: Daubner-Bendes, Rita, et al.
Publicado: (2021)

Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens
por: Kardas, Przemysław, et al.
Publicado: (2021)

The Importance of the Mining Subsidence Reservoirs Located Along the Trans-Regional Highway in the Conservation of the Biodiversity of Freshwater Molluscs in Industrial Areas (Upper Silesia, Poland)
por: Lewin, Iga, et al.
Publicado: (2015)

GMS-HTA: Information out of the world of HTA - up-to-date, comprehensive and valid
por: Rüther, Alric
Publicado: (2005)

From recommendation to action: psychosocial factors influencing physician intention to use Health Technology Assessment (HTA) recommendations
por: Gagnon, Marie-Pierre, et al.
Publicado: (2006)

Prevalence of Chronic Polypharmacy in Community-Dwelling Elderly People in Poland: Analysis of National Real-World Database Helps to Identify High Risk Group
por: Kardas, Przemysław, et al.
Publicado: (2021)

HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations
por: Hoxhaj, Ilda, et al.
Publicado: (2022)

Using the Dynamic SWOT Analysis to Assess Options for Implementing the HB-HTA Model
por: Więckowska, Barbara, et al.
Publicado: (2022)

The Impact of Brexit on Pharmaceuticals and HTA
por: Lorgelly, Paula K
Publicado: (2018)

HTA and National Immunisation Program: an overview of competent bodies and of the impact of HTA on the decision-making process
por: Ricciardi, W
Publicado: (2022)

Mercury Content in Dietary Supplements From Poland Containing Ingredients of Plant Origin: A Safety Assessment
por: Puścion-Jakubik, Anna, et al.
Publicado: (2021)

HTA26 Health Technology Assessment (HTA) Methods for Monoclonal Antibodies for Treatment and Prevention of COVID-19
por: Warttig, S, et al.
Publicado: (2022)

HTA253 Payer Perspectives on the Impact of the COVID-19 Pandemic on Health Technology Assessments (HTA) in Europe
por: Hutcheson, R, et al.
Publicado: (2022)

The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders
por: Wasir, Riswandy, et al.
Publicado: (2019)

5.M. Workshop: The need to account for vaccine-specificities in the implementation of the EU Regulation on HTA
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_djodgda9v0chn49r1808g1bdlf